rs190922596
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_032119.4(ADGRV1):āc.3191A>Cā(p.Glu1064Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0021 in 1,613,958 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_032119.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADGRV1 | NM_032119.4 | c.3191A>C | p.Glu1064Ala | missense_variant | 17/90 | ENST00000405460.9 | NP_115495.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADGRV1 | ENST00000405460.9 | c.3191A>C | p.Glu1064Ala | missense_variant | 17/90 | 1 | NM_032119.4 | ENSP00000384582.2 | ||
ADGRV1 | ENST00000640403.1 | c.494A>C | p.Glu165Ala | missense_variant | 7/29 | 5 | ENSP00000492531.1 | |||
ADGRV1 | ENST00000504142.2 | n.1957A>C | non_coding_transcript_exon_variant | 11/14 | 5 | |||||
ADGRV1 | ENST00000639676.1 | n.789A>C | non_coding_transcript_exon_variant | 5/11 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00190 AC: 289AN: 152180Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00206 AC: 513AN: 249068Hom.: 2 AF XY: 0.00197 AC XY: 266AN XY: 135106
GnomAD4 exome AF: 0.00212 AC: 3096AN: 1461660Hom.: 7 Cov.: 33 AF XY: 0.00201 AC XY: 1463AN XY: 727110
GnomAD4 genome AF: 0.00189 AC: 288AN: 152298Hom.: 0 Cov.: 32 AF XY: 0.00187 AC XY: 139AN XY: 74476
ClinVar
Submissions by phenotype
not specified Benign:3
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Dec 21, 2017 | p.Glu1064Ala in exon 17 of ADGRV1: This variant is not expected to have clinical significance because it has been identified in 0.3% (371/126508) of European ch romosomes including one homozygote by the Genome Aggregation Database (gnomAD, h ttp://gnomad.broadinstitute.org; dbSNP rs190922596). ACMG?AMP criteria applied: BS1 - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Apr 12, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jul 23, 2014 | - - |
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2023 | ADGRV1: BP4, BS2 - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 19, 2020 | This variant is associated with the following publications: (PMID: 23804846, 22334370) - |
Febrile seizures, familial, 4 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Aug 27, 2013 | - - |
Usher syndrome type 2C Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
Retinitis pigmentosa Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | DBGen Ocular Genomics | Jan 01, 2021 | Class 3 ACMG Guidelines, 2015 - |
ADGRV1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 24, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at